Skip to main content

Peer Review reports

From: Protective effects of rolipram on endotoxic cardiac dysfunction via inhibition of the inflammatory response in cardiac fibroblasts

Original Submission
4 Oct 2019 Submitted Original manuscript
8 Nov 2019 Reviewed Reviewer Report
16 Nov 2019 Reviewed Reviewer Report
6 Dec 2019 Author responded Author comments - Jingjing Ji
20 Dec 2019 Reviewed Reviewer Report
2 Jan 2020 Reviewed Reviewer Report
7 Jan 2020 Author responded Author comments - Jingjing Ji
Resubmission - Version 2
6 Dec 2019 Submitted Manuscript version 2
20 Jan 2020 Reviewed Reviewer Report
10 Feb 2020 Reviewed Reviewer Report
18 Feb 2020 Author responded Author comments - Jingjing Ji
Resubmission - Version 3
18 Feb 2020 Submitted Manuscript version 3
26 Feb 2020 Reviewed Reviewer Report
4 Mar 2020 Reviewed Reviewer Report
20 Mar 2020 Author responded Author comments - Jingjing Ji
Resubmission - Version 4
20 Mar 2020 Submitted Manuscript version 4
6 May 2020 Author responded Author comments - Jingjing Ji
Resubmission - Version 5
6 May 2020 Submitted Manuscript version 5
11 May 2020 Author responded Author comments - Jingjing Ji
Resubmission - Version 6
11 May 2020 Submitted Manuscript version 6
Publishing
14 May 2020 Editorially accepted
24 May 2020 Article published 10.1186/s12872-020-01529-7

You can find further information about peer review here.

Back to article page